Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Reviews in Cardiovascular MedicineOpen Access

The Systemic Immune–Inflammation Index Predicts Long-Term Outcomes in Patients With Unstable Angina and Diabetes After Revascularization

View Full Paper
Ask AI
Bookmark
Share

Authors

XBXiaowen BoTZTian ZhouHZHao Zhang

Discussion

Loading...

Member takes

Overview

Observational analysis identifies high systemic immune-inflammation index as a risk factor for major adverse cardiovascular events in unstable angina patients with diabetes.

Key Points

  • Elevated systemic immune-inflammation index levels correlate with poorer long-term outcomes in unstable angina patients.
  • 23 patients (10.5%) in the low systemic immune-inflammation index group and 34 (24.3%) in the high group faced major adverse cardiovascular events.
  • The study examined 937 unstable angina patients, with a focus on those also diagnosed with diabetes mellitus.
  • Regular monitoring and controlling inflammation levels may enhance long-term outcomes for patients post-revascularization.

Cite This Study

Bo et al. (2025) studied this question.

synapsesocial.com/papers/68c23d3ab210217d6478d142https://doi.org/10.31083/rcm36261
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic value of systemic immune-Inflammatory index in patients with diabetes mellitus and acute coronary syndrome after percutaneous coronary intervention: a prospective cohort study2025
  2. 2Risk Stratification in Acute Coronary Syndromes: The Systemic Immune-Inflammation Index as Prognostic Marker2025 · 11 citations
  3. 3Prognostic Value of Systemic Immune‐Inflammation Index (SII) in Hospital Readmission Following Acute Myocardial Infarction: A Four‐Year Analysis2026
  4. 4Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 20172018 · 8,778 citations
  5. 5Systemic inflammation markers and cancer incidence in the UK Biobank2021 · 542 citations